Pfizer og BioNTech mener vaksine de utvikler er 90 prosent effektiv mot corona.
Legemiddelselskapet Pfizer har publisert foreløpige analyser av vaksinen de utvikler sammen med det tyske bioteknologifirmaet BioNTech mandag.
Legemiddelselskapet Pfizer har publisert foreløpige analyser av vaksinen de utvikler sammen med det tyske bioteknologifirmaet BioNTech mandag.
Copyright © 2024 | Alle rettigheter reservert 3FM-Norge
Infokapsel | Varighet | Beskrivelse |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |